Topical cyclosporine treatment in inflammatory nodular acne

European Journal of Dermatology

Volumn 18, Issue 6, 2008, Pages 716-717

  Ciftci, Suleyman ^a  

^a Batman State Hospital   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; CYCLOSPORIN; RETINOID;

ABSENCE OF SIDE EFFECTS; ACNE; ADJUVANT THERAPY; ADULT; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CASE REPORT; DRUG EFFICACY; FACE EDEMA; FOLLOW UP; HUMAN; MALE; NODULAR ACNE; SKIN NODULE; TREATMENT DURATION;

ACNE VULGARIS; ADMINISTRATION, TOPICAL; CYCLOSPORINE; FACIAL DERMATOSES; HUMANS; IMMUNOSUPPRESSIVE AGENTS; MALE;

EID: 57749196126     PISSN: 11671122     EISSN: None     Source Type: Journal    
DOI: 10.1684/ejd.2008.0527     Document Type: Article

References (4)

1. Small DS, Acheampong A, Reis B, et al. Blood concentrations of cyclosporin a during long-term treatment with cyclosporin a ophthalmic emulsions in patients with moderate to severe dry eye disease. J Ocul Pharmacol Ther 2002; 18: 411-8.
2. Burgdorf W. Acne vulgaris. Eur J Dermatol 2008; 18 (1): 107-8.
3. Gollnick H, Cunliffe W, Berson D, Dreno B, Finlay A, Leyden JJ, Shalita AR, Thiboutot D. Global Alliance to Improve Outcomes in Acne. J Am Acad Dermatol 2003; 49: 1-37.
4. Dréno B, Bettoli V, Ochsendorf F, et al. An expert view on the treatment of acne with systemic antibiotics and/or oral isotretinoin in the light of the new European recommendations. Eur J Dermatol 2006; 16: 565-71.